Pivotal clinical study of Erythropoietin for the treatment of sudden cardiac arrest
Latest Information Update: 09 Feb 2023
At a glance
- Drugs Erythropoietin (Primary)
- Indications Reperfusion injury
- Focus Registrational; Therapeutic Use
Most Recent Events
- 09 Feb 2023 New trial record
- 02 Feb 2023 According to a Rosalind Franklin University of Medicine and Science media release, pre-IND meeting carried out with the FDA's Division of Cardiology and Nephrology in the fourth quarter of 2022.
- 02 Feb 2023 According to a Rosalind Franklin University of Medicine and Science media release, the company looking to finalize its IND application during the first quarter of 2023 and to initiate this study early next year.